Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 22 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
211 25.5 months Metastatic breast cancer 4 Chemotherapy
Hellenic Oncology Research Group Greece 6/2012
Treatment Details: Patients: This phase 2 study involved 29 women with metastatic breast cancer who had been previously treated with anthracyclines and taxanes. The median patient age was 58 years. Treatm
 
212 25.5 months Advanced breast cancer 4 Chemotherapy
Karolinska Institutet and University Hospital Sweden 2/2012
Treatment Details: Patients: This phase III study involved women with advanced breast cancer who were separated into two separate treatment groups. Group A consisted of 296 patients with a median age of 54 y
 
213 25.5 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Klinikum Muenchen-Grosshadern Germany 3/2011
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 89 patients with a median age of 63 ye
 
214 25.4 months Metastatic breast cancer 4 Chemotherapy
Institut Català d'Oncologia (ICO), Hospital Universitario Josep Trueta Spain 7/2009
Treatment Details: Patients: This phase I/II study involved 53 women with metastatic or locally advanced breast cancer. The median age of these women was 59, ranging from 32 to 79 years of age. The majority
 
215 25.4 months colon cancer (metastatic) 4 Chemotherapy
Geneva University Hospital Switzerland 5/2005
Treatment Details: Patients: This Phase I/II study involved 30 patients with metastatic colorectal cancer. Twenty-four patients were men, and six were women. The median age was 58. The primary sites were co
 
216 25.4 months rectal cancer (metastatic) 4 Chemotherapy
Geneva University Hospital Switzerland 5/2005
Treatment Details: Patients: This Phase I/II study involved 30 patients with metastatic colorectal cancer. Twenty-four patients were men, and six were women. The median age was 58. The primary sites were co
 
217 25.4 months Hepatocellular carcinoma 5 Chemotherapy
Immunotherapy
California Pacific Medical Center United States 9/2009
Treatment Details: Patients: This phase 2 study involved hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A had 14 patients with an average age of 59.2 years and 7
 
218 25.4 months Metastatic Colorectal Cancer 4 Biologic therapy
Kantonsspital St Gallen Switzerland 1/2015
Treatment Details: Patients: This phase 3 study involved 131 previously treated metastatic colorectal cancer patients. The median patient age was 63 years and 71% were male. Treatment: Patients received
 
219 25.2 months Platinum-resistant or platinum-refractory ovarian cancer 4 Immunotherapy
University of Pittsburgh School of Medicine United States 8/2009
Treatment Details: Patients: This phase 2 study involved 31 women with platinum resistant or platinum refractory ovarian cancer. The median age was 51, ranging from 29 to 75 years of age. Treatment: Patien
 
220 25.0 months Metastatic breast cancer 4 Chemotherapy
Charing Cross Hospital, Imperial College London United Kingdom 7/2009
Treatment Details: Patients: This phase 2 study involved 51 women with metastatic breast cancer. Their median age was 55, ranging from 35 to 69. Treatment: These patients were treated with the chemothe
 
Page 22 of 187  | Previous Page  | Next Page